Skip to main content

Published locations for Halving the TKI dose safe, cost effective in CML patients with stable remissions

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Halving the TKI dose safe, cost effective in CML patients with stable remissions

User login

  • Reset your password
  • /content/halving-tki-dose-safe-cost-effective-cml-patients-stable-remissions
  • /hematologynews/article/119417/cml/halving-tki-dose-safe-cost-effective-cml-patients-stable
  • /oncologypractice/article/119417/cml/halving-tki-dose-safe-cost-effective-cml-patients-stable
  • /hematology-oncology/article/119417/cml/halving-tki-dose-safe-cost-effective-cml-patients-stable